Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,432.00 ILa | +1.80% |
|
-7.26% | -6.52% |
| 02:10am | Chip stocks take a long weekend |  |
| 06-18 | FDA Seeks Updated Labeling for Testosterone Therapies | MT |
| Market Cap | 36.66B 0 31.96B 29.6B 27.71B 51.97B 3,459B 52.28B 351B 136B 1,702B 138B 135B 5,911B | P/E 2026 * |
31.6x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 47.69B 0 41.58B 38.51B 36.05B 67.61B 4,500B 68.02B 457B 177B 2,215B 179B 175B 7,690B | EV / Sales 2026 * |
2.86x | EV / Sales 2027 * | 2.59x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | +1.80% | ||
| 1 week | -7.26% | ||
| Current month | -4.15% | ||
| 1 month | -4.53% | ||
| 3 months | +3.05% | ||
| 6 months | -2.04% | ||
| Current year | -6.52% |
| 1 week | 9,221 |  | 10,230 |
| 1 month | 9,221 | | 10,240 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 2,695 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 21,770 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 2022-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 2019-12-21 |
Matthew Shields
COO | Chief Operating Officer | 52 | 2024-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 2008-12-31 |
Sol Barer
CHM | Chairman | 78 | 2017-02-05 |
Rosemary Crane
BRD | Director/Board Member | 65 | 2015-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.80% | -7.26% | - | - | 36.66B | |
| +32.62% | -5.37% | +39.94% | +145.38% | 980B | |
| -3.20% | -4.17% | +51.52% | +39.07% | 550B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 382B | |
| -1.75% | +0.25% | +25.86% | +16.53% | 317B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 270B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 269B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 191B | |
| -1.90% | -4.65% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 154B | |
| Average | -0.27% | -2.68% | +19.43% | +39.89% | 366B | |
| Weighted average by Cap. | -0.94% | -3.38% | +28.25% | +64.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.65B 0 14.52B 13.44B 12.59B 23.6B 1,571B 23.75B 159B 61.81B 773B 62.5B 61.15B 2,685B | 17.26B 0 15.05B 13.94B 13.05B 24.47B 1,629B 24.62B 165B 64.08B 802B 64.79B 63.4B 2,783B |
| Net income | 1.74B 0 1.51B 1.4B 1.31B 2.46B 164B 2.48B 16.64B 6.45B 80.66B 6.52B 6.38B 280B | 2.72B 0 2.37B 2.2B 2.06B 3.86B 257B 3.88B 26.05B 10.1B 126B 10.21B 9.99B 439B |
| Net Debt | 11.03B 0 9.62B 8.91B 8.34B 15.64B 1,041B 15.73B 106B 40.96B 512B 41.41B 40.52B 1,779B | 8.01B 0 6.99B 6.47B 6.06B 11.36B 756B 11.43B 76.76B 29.75B 372B 30.08B 29.43B 1,292B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 9,432.00 ILa | +1.80% | 1,907,059 |
| 26-06-18 | 9,265.00 ILa | -2.83% | 1,141,221 |
| 26-06-17 | 9,535.00 ILa | -1.69% | 810,016 |
| 26-06-16 | 9,699.00 ILa | -2.52% | 904,000 |
| 26-06-15 | 9,950.00 ILa | -2.16% | 795,091 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
